急性辐射损伤的细胞因子联合治疗研究进展

邢爽; 李明; 黄海潇; 罗庆良

急性辐射损伤的细胞因子联合治疗研究进展

邢爽 , 李明 , 黄海潇 , 罗庆良

文章导航 > 国际放射医学核医学杂志 > 2008, 32 > 1: (47-50)

引用本文:

Citation:

急性辐射损伤的细胞因子联合治疗研究进展

100850 北京, 军事医学科学院放射与辐射医学研究所放射病实验治疗研究室

通讯作者: 罗庆良, luoqingliang52@yahoo.com.cn

基金项目:
"十一五"全军医药卫生科研项目(062064)
中图分类号: Q691;R818.05

Cytokines combination in acute radition injury management

Department of Experimental Therapy of Radiation Sickness, Beijing Institute of Radiation Medicine, Beijing 100850, China

Corresponding author: LUO Qing-liang, luoqingliang52@yahoo.com.cn

CLC number: Q691;R818.05

摘要: 细胞因子对急性辐射损伤的治疗作用日益受到重视,尤其是造血生长因子抗辐射作用的研究取得了长足进展。但随着照射剂量的增加,造血干,祖细胞大量死亡及皮肤和胃肠道等非造血系统损伤加重,单一的细胞因子难以逆转严重损伤,因此细胞因子的联合应用成为必然。当前,细胞因子联合治疗急性辐射损伤的研究主要集中于造血生长因子及抗凋亡细胞因子联合应用效果的评价,结果提示,照射后早期细胞因子联合应用是事故性辐射损伤的有效治疗措施。
- 辐射损伤 /
- 细胞因子 /
- 造血生长因子
Abstract: Cytokine-based treatment was well applied to manage acute radiation injury in recent years.Unfortunately, efficacy of single cytokine was reduced because of multiple organs severe injury caused by high dose irradiation. It is the rationale for cytokines combination. Anti-radiation efficacy of cytokines combination were reviewed, especially hematopoietic growth factors and antiappoptic cytokines combined in acute radiation injury management were documented. Emergency cytokines combination would be an alternative for acute radiation injury treatment.
- Radiation injuries /
- Cytokines /
- Hematopoietic growth factors
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	Li Z, Wenyi Z, Liang'an Z. General situation of radiation accidents in China[J]. Radiat Prot Dosimety, 2007, 124(2):177-180.
[2]	Weisdorf D, ChaoN, Waselenko JK, et al. Acute radiation injury:contingency planning for triage,supportive care, and transplantation[J]. Biol Blood Marrow Transplant, 2006, 12(6):672-682.
[3]	罗庆良,从玉文,郝静,等.造血因子与急性放射病[J].解放军医学杂志,2005,30(3):186-190.
[4]	Van der Meeren A, Mouthon MA, Gautgler MH, et al. Administration of recombinant human interleukin-11 after supralethal radiation exposure promotes survival in mice:interactive effect with thrombopoietin[J]. Radiat Res, 2002, 157(6):642-649.
[5]	Farese AM, Hunt P, Grab LB, et al. Combined administration of recombinant human megakaryocyte growth factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation induced marrow aplasia[J]. J Clin Invest, 1996, 97(9):2145-2151.
[6]	Karen KJ, Dubbelman YD, Luo QL, et al. Simultaneous TPO and G-CSF treatment following cytoreductive treatment of rhesus monkeys prevents thrombocytpenia, accelerates platelet and red cell reconstitution, allevates neutropenia and promotes the recovery if immature bone marrow cells[J]. Exp Hematol, 1997, 25(10):1084.
[7]	郝静,罗庆良,熊国林,等.rhIL-11加rhG-CSF对8.0Gy照射猴的治疗作用[J].解放军医学杂志,2001,26(10):730-732.
[8]	邢爽,黄海潇,熊国林,等.重组人粒细胞集落刺激因子和重组人白介素11对3.5Gy照射狗的治疗作用[J].军事医学科学院院刊,2007,31(4):394-396.
[9]	赵杰,赵翔宇,黄晓军.白细胞介素11联合粒细胞集落刺激因子对小鼠异基因骨髓移植后移植物抗宿主病影响的研究[J].中华医学杂志,2005,85(35):2497-2502.
[10]	Farese AM, Williams DE, Seiler FR, et al. Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiationinduced marrow aplasia[J]. Blood, 1993, 82(10):3012-3018.
[11]	崔玉芳,杨红,罗庆良,等.rhIL-3和GM-CSF对γ线照射猴外周血淋巴细胞损伤的防护作用研究[J].中国危重病急救医学,2004,16(1):22-25.
[12]	Drouet M, Mourcin F, Grenier N, et al. The effects of ionizing radiation on stem cells and hematopoietic progenitors:the place of apoptosis and the therapeutic potential of anti-apoptosis treatments[J]. Can J Physiol Pharmacol, 2002, 80(7):700-709.
[13]	Hérodin F, Bourin P, Mayol JF, et al. Short term injection of antiapoptotic cytokine combinations soon after lethal gamma irradiation promotes survival[J]. Blood, 2003, 101(7):2609-2616.
[14]	Droute M, Mourcin F, Grenier N, et al. Single administration of stem cell factor, Fit-3 ligand, megakaryocyte growth and development factor, and interleukin-3 in combination soon after irradiation prevents nonhuman primates from myelosuppression:long-term follow-up of hematopoiesis[J]. Blood, 2004, 103(3):878-885.
[15]	Hérodin F, Roy L, Grenier N, et al. Antiapoptotie eytokines in combination with pegfilgrastim soon after irradiation mitigates myelosuppression in nonhuman primates exposed to high irradiation dose[J]. Exp Hematol, 2007, 35(8):1172-1181.
[16]	Hérodin F, Drouet M. Cytokine-based treatment of accidentally irradiated victims and new approaches[J]. Exp Hematol, 2005, 33(10):1071-1080.
[17]	Hérodin F, Grenier N, Drouet M. Revisting therapeutic strategies in radiation casuahies[J]. Exp Hematol, 2007, 35(4 suppl 1):28-33.
[18]	Meineke V, Fliedner TM. Radiation-induced multi-organ involvement and failure:challenges for radiation accident medical management and future research[J]. BJR Suppl, 2005, 27:196-200.
[19]	邢爽,黄海潇,罗庆良.角质细胞生长因子对上皮细胞损伤的防护作用[J].国外医学药学分册,2006,33(2):97-99.
[20]	Alpdogan O, Hubbard VM, Smith OM, et al. Keratinocyte growth factor (KGF) is required for postnatal thymic regeneration[J]. Blood, 2006, 107(6):2453-2460.

[1]	闵锐 . 辐射损伤防护药及细胞因子治疗研究动态. 国际放射医学核医学杂志, 2004, 28(4): 173-178.
[2]	刘玉龙 , 周剑影 , 王国权 . 应用细胞因子治疗放射损伤的研究现状. 国际放射医学核医学杂志, 1999, 23(2): 86-89.
[3]	曹京旭 , 张旭志 . 细胞因子与放射性肺损伤. 国际放射医学核医学杂志, 2001, 25(4): 181-185.
[4]	闫风琴 , 鞠桂芝 . 辐射及细胞因子对p21基因表达的调控作用. 国际放射医学核医学杂志, 2004, 28(6): 278-280.
[5]	苗莉 , 缪竞诚 . 细胞因子在急性辐射损伤治疗中的作用. 国际放射医学核医学杂志, 2006, 30(3): 173-176.
[6]	陈文韩 , 谢蓉星 , 陈少珠 . 甲状腺激素及骨代谢相关细胞生长因子水平对甲状腺功能亢进症患者的影响. 国际放射医学核医学杂志, 2008, 32(4): 227-229.
[7]	陆忠华 , 周菊英 , 许锡元 . 转化生长因子β1与放射性肺损伤. 国际放射医学核医学杂志, 2006, 30(4): 247-249.
[8]	罗成基 . 白细胞介素-3与辐射损伤. 国际放射医学核医学杂志, 1995, 19(6): 263-266.
[9]	王欣悦 , 王月 , 李文璇 , 霍启东 , 董银萍 , 唐生安 , 李德冠 . 蔓荆子提取物对小鼠造血系统辐射损伤的防护作用. 国际放射医学核医学杂志, 2023, 47(6): 354-361. doi: 10.3760/cma.j.cn121381-202207013-00309
[10]	陈孟毅 , 林帅 , 吴丽贤 , 刘冰 , 李程程 , 李德冠 , 孟爱民 . 不同年龄小鼠造血系统辐射损伤与修复的比较观察. 国际放射医学核医学杂志, 2019, 43(5): 442-449. doi: 10.3760/cma.j.issn.1673-4114.2019.05.011

点击查看大图

计量

文章访问数: 1411
HTML全文浏览量: 98
PDF下载量: 5

急性辐射损伤的细胞因子联合治疗研究进展

通讯作者: 罗庆良, luoqingliang52@yahoo.com.cn

100850 北京, 军事医学科学院放射与辐射医学研究所放射病实验治疗研究室

收稿日期: 2007-10-09

基金项目: "十一五"全军医药卫生科研项目(062064)

关键词:

摘要: 细胞因子对急性辐射损伤的治疗作用日益受到重视,尤其是造血生长因子抗辐射作用的研究取得了长足进展。但随着照射剂量的增加,造血干,祖细胞大量死亡及皮肤和胃肠道等非造血系统损伤加重,单一的细胞因子难以逆转严重损伤,因此细胞因子的联合应用成为必然。当前,细胞因子联合治疗急性辐射损伤的研究主要集中于造血生长因子及抗凋亡细胞因子联合应用效果的评价,结果提示,照射后早期细胞因子联合应用是事故性辐射损伤的有效治疗措施。